Back to search

Article

“PBT-SCREEN”, a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3

2023-08-25

Abstract excerpt

<h4>Background: </h4> Pediatric brain tumors (PBTs) represent about 25% of all pediatric cancers and are the most common solid tumors in children and adolescents. Medulloblastoma (MB) is the most frequently occurring malignant PBT, accounting for almost 10% of all pediatric cancer deaths. MB Group 3 (MB G3) accounts for 25–30% of all MB cases and has the worst outcome, particularly when associated with MYC amplifi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9ea8937e-171e-59b6-bfda-e055d2e31212
DOI
10.21203/rs.3.rs-3286730/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
“PBT-SCREEN”, a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3DOI 10.21203/rs.3.rs-3286730/v1
Patient-Derived Orthotopic Xenografts and Cell Lines from Pediatric High-Grade Glioma Recapitulate the Heterogeneity of Histopathology, Molecular Signatures, and Drug ResponseSemantic proximity
Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastomaSemantic proximity
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunitiesSemantic proximity
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.Semantic proximity
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.Semantic proximity
DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.Semantic proximity
Frondoside A Inhibits an MYC-Driven Medulloblastoma Model Derived from Human-Induced Pluripotent Stem CellsSemantic proximity
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastomaSemantic proximity
Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma TreatmentSemantic proximity
The Children’s Brain Tumor Network (CBTN) - Accelerating Research in Pediatric Central Nervous System Tumors through Collaboration and Open ScienceSemantic proximity
ONC206 demonstrates potent anti-tumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastomaSemantic proximity
Cytogenetic and molecular biological characterization of an adult medulloblastoma.Semantic proximity
Select a neighboring publication to make it the new centre.